Logo

American Heart Association

  22
  0


Final ID: Sa3083

Pulmonary Hypertension Due to Fibrous Mediastinitis Treated Successfully with Stenting of Pulmonary Artery Stenoses

Abstract Body (Do not enter title and authors here): Introduction:Fibrosing mediastinitis is a rare condition characterized by excessive fibrous tissue proliferation in the mediastinum, leading to compression of vital structures. We present a case of idiopathic fibrosing mediastinitis with progressive pulmonary hypertension and multi-vessel stenosis, highlighting diagnostic challenges and management strategies. Research Questions: The case explores the clinical and imaging features of fibrosing mediastinitis, its differentiation from other causes of pulmonary hypertension, and the potential treatment options for fibrosing mediastinitis-related vascular obstruction. Aims: This case aims to (1) describe the clinical course and diagnostic pitfalls in a patient with long-standing fibrosing mediastinitis, (2) evaluate the role of imaging and invasive testing in diagnosis, and (3) assess the efficacy of endovascular stenting in symptomatic relief. Methods: A 58-year-old male with a 5-year history of recurrent dyspnea and chest tightness underwent serial evaluations, including CT angiography, echocardiography, pulmonary function tests, bronchoscopy, and right heart catheterization. After failing medical therapy, he underwent percutaneous pulmonary artery stenting. Results: Imaging revealed mediastinal lymphadenopathy with calcification, pulmonary artery stenosis, and tracheobronchial compression. Pulmonary arteriography confirmed severe stenosis in multiple pulmonary arteries. Stent implantation improved exercise capacity (6-minute walk distance: 360m to 485m) and oxygen saturation. Conclusions: Fibrosing mediastinitis is a rare but treatable cause of pulmonary hypertension. A high index of suspicion is needed in patients with progressive dyspnea and mediastinal fibrosis. Endovascular stenting may provide symptomatic relief in select cases, though long-term outcomes require further study.
  • Wu, Yihao  ( Hangzhou First People's Hospital , Hangzhou , China )
  • Author Disclosures:
    yihao wu: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Signals Under Pressure: Molecular Pathways in Pulmonary Hypertension

Saturday, 11/08/2025 , 10:30AM - 11:30AM

Abstract Poster Board Session

More abstracts on this topic:
Breaking the Barrier: RAGE Deficiency Promotes EndoMT and Male-Predominant Pulmonary Arterial Hypertension

Lawal Odunayo, Niihori Maki, Rafikov Ruslan, Rafikova Olga

Catheter-Directed Interventions for High-Risk Acute Pulmonary Embolism in patients with Liver Cirrhosis

Kumar Manoj, Gomez Valencia Javier, Ricciardi Mark, Arman Qamar, Ali Shafaqat, Nso Nso, Jamshed Aneeza, Murthi Mukunthan, Kumar Nomesh, Kumar Sanjay, Kumari Rinkle, Alraies M Chadi

You have to be authorized to contact abstract author. Please, Login
Not Available